Tiblio
Sign Up

GRDN

Guardian Pharmacy Services, Inc.
NYSEHEALTHCAREMEDICAL CARE FACILITIES

Key Statistics

Market Cap
$2.41B
P/E Ratio
36.89
EPS
$1.03
Beta
—
52W High
$47.02
52W Low
$23.14
50-Day MA
$40.83
200-Day MA
$35.10
Dividend Yield
—
Profit Margin
4.50%
Forward P/E
29.76
PEG Ratio
—

About Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services, Inc. is a leading provider of specialized pharmacy solutions focused on the long-term care sector, servicing assisted living and skilled nursing facilities. Known for its commitment to personalized medication management and stringent quality standards, the company leverages advanced technology and deep pharmaceutical expertise to enhance patient outcomes. With an extensive operational presence across multiple states, Guardian is well-positioned to address the growing demand for customized pharmacy services, ensuring optimal operational efficiency for its healthcare partners in an evolving market.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$1.46B
Gross Profit (TTM)$316.58M
EBITDA$109.41M
Operating Margin3.48%
Return on Equity30.40%
Return on Assets13.50%
Revenue/Share (TTM)$23.22
Book Value$3.49
Price-to-Book9.91
Price-to-Sales (TTM)1.65
EV/Revenue1.626
EV/EBITDA19.86
Quarterly Earnings Growth (YoY)139.80%
Quarterly Revenue Growth (YoY)2.20%
Shares Outstanding$49.80M
Float$32.01M
% Insiders37.51%
% Institutions60.60%

Historical Volatility

HV 10-Day
69.72%
HV 20-Day
56.36%
HV 30-Day
47.92%
HV 60-Day
45.41%
HV Rank
77.8%

Volatility is currently expanding

Analyst Ratings

Consensus ($48.83 target)
1
Strong Buy
5
Buy

Latest News

Guardian Pharmacy Services Reports Second Quarter 2026 Financial Results; Raises Full-Year Guidance

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the second quarter ended June 30, 2026. The Company also raised its full-year guidance. Second Quarter Financial Results Revenue of $351.8 million, up 2% year-over-year. Residents served ended the quarter at approximately 210,000, up 8% year-over-year. Net Income of $22.1 million, inclusive of an $8.5 m.

Business Wire8/6/2026Neutral
Guardian Pharmacy Services, Inc. to Report Second Quarter 2026 Financial Results and Host Conference Call

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will release second quarter 2026 financial results after market close on Thursday, August 6, 2026. Management will host a conference call to discuss the results at 4:30 p.m. Eastern Time. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing +1 (833) 461-5787 for participants located in the United.

Business Wire7/15/2026Neutral
Guardian Pharmacy Services, Inc. Announces Leadership Transitions

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that Kendall Forbes, who has served as Executive Vice President of Sales & Operations since 2004, has decided to retire, effective as of July 1, 2026. Upon Mr. Forbes's retirement, David Morris, currently Executive Vice President and Chief Financial Officer of Guardian will assume the role of Chief Operating Officer. In connection with Mr. Morris' new role, Will Mudd, Senior Vice President, Finance, has b.

Business Wire6/22/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on GRDN and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

LLYEli Lilly and CompanyJNJJohnson & JohnsonABBVAbbVie IncUNHUnitedHealth Group IncorporatedMRKMerck & Company IncNVSNovartis AG ADRAZNAstraZeneca PLCAMGNAmgen IncTMOThermo Fisher Scientific IncNVONovo Nordisk A/SABTAbbott LaboratoriesGILDGilead Sciences Inc
View all HEALTHCARE stocks →
Data last updated: 8/18/2026